Thrombocytopenia resident survival guide: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 118: | Line 118: | ||
====WHO Bleeding Grades==== | ====WHO Bleeding Grades==== | ||
Below is a table depicting the WHO bleeding grades for therapeutic platelet transfusion.<ref name="pmid18024626">{{cite journal| author=Slichter SJ| title=Evidence-based platelet transfusion guidelines. | journal=Hematology Am Soc Hematol Educ Program | year= 2007 | volume= | issue= | pages= 172-8 | pmid=18024626 | doi=10.1182/asheducation-2007.1.172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18024626 }} </ref> | Below is a table depicting the WHO bleeding grades for therapeutic platelet transfusion.<ref name="pmid18024626">{{cite journal| author=Slichter SJ| title=Evidence-based platelet transfusion guidelines. | journal=Hematology Am Soc Hematol Educ Program | year= 2007 | volume= | issue= | pages= 172-8 | pmid=18024626 | doi=10.1182/asheducation-2007.1.172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18024626 }} </ref><ref name="pmid19503635">{{cite journal| author=Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group| title=Recommendations for the transfusion of plasma and platelets. | journal=Blood Transfus | year= 2009 | volume= 7 | issue= 2 | pages= 132-50 | pmid=19503635 | doi=10.2450/2009.0005-09 | pmc=PMC2689068 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19503635 }} </ref> | ||
{| Class="wikitable" | {| Class="wikitable" | ||
! Grade 0 | ! Grade 0 |
Revision as of 20:21, 29 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Definition
Thrombocytopenia is the decreased concentration of platelets below 150,000 cells per microliter of blood.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Abruptio placentae[1]
- Bone marrow suppression (chemotherapy, irradiation)
- Cardica bypass[1]
- Chronic alcohol use
- Chronic liver disease[2]
- Common variable immunodeficiency[1]
- Congenital thrombocytopenia
- Connective tissue disorders (eg SLE, RA, antiphospholipid syndrome)[1]
- Disseminated intravascular coagulation[2]
- GP IIb/IIIa inhibitor[1]
- Hemolytic uremic syndrome
- Heparin-induced thrombocytopenia
- Immune thrombocytopenic purpura[3]
- Infections[2]
- Macrophage-activation syndrome[1]
- Medications[2]
- Preeclampsia
- Pregnancy[4]
- Pseudothrombocytopenia
- Thrombotic thrombocytopenic purpura[5]
Management
Shown below is an algorithm depicting the initial approach to thrombocytopenia.[1]
Characterize the symptoms: ❑ Onset (acute, chronic, recurrent) ❑ Easy bruising ❑ Petechia ❑ Rashes ❑ Melena ❑ Fevers ❑ Bleeding ❑ Headaches ❑ Abdominal pain ❑ Visual disturbances ❑ Weight loss ❑ Night sweats ❑ Bone pain Obtain a detailed history: ❑ Recent medications ❑ Pregnancy ❑ Family history ❑ Malignancy ❑ Recent infection ❑ Recent vaccinations ❑ Recent travels ❑ Recent transfusions ❑ Chronic alcohol use ❑ Recent hospitalization ❑ Recent organ transplantation ❑ Recent valve replacement surgery ❑ Dietary habits ❑ Sexual history ❑ Ingestion of quinine containing beverages | |||||||||||||
Examine the patient: ❑ Bleeding location ❑ Bleeding severity ❑ Hepatomegaly ❑ Splenomegaly ❑ Mucocutaneous bleeding ❑ Skeletal abnormalities ❑ Joint or soft tissue bleeding ❑ Rash ❑ Generalized lymphadenopathy ❑ Skin necrosis ❑ Neurological exam | |||||||||||||
Order tests: ❑ Peripheral blood smear ❑ CBC and differential ❑ Reticulocyte count ❑ LDH ❑ LFT ❑ Renal function test ❑ Clotting screen
| |||||||||||||
❑ Order additional tests based on the results of the CBC-D and peripheral blood smear | |||||||||||||
Possible Pseudothrombocytopenia ❑ Clumped platelets | True thrombocytopenia | ||||||||||||||||||||||||
❑ Order platelet count on heparinized blood specimen | Isolated thrombocytopenia | Thrombocytopenia with abnormalities in other blood lineages | |||||||||||||||||||||||
Guide your next step by specific findings | |||||||||||||||||||||||||
Consider: | Look for: ❑ Schistocytes ❑ Spherocytes ❑ Dacrocytes ❑ Blasts ❑ Giant platelets ❑ Granulations ❑ Hypersegmented neutrophils ❑ Macrocytosis ❑ Lymphocytosis ❑ Neutropenia | ||||||||||||||||||||||||
Note that the treatment of thrombocytopenia is specific to the underlying cause of thrombocytopenia.
Diagnostic Clues
Shown below is a table summarizing different findings on the peripheral blood smear findings and their associated conditions.[1]
Findings on the peripheral blood smear | Associated conditions |
---|---|
Giant platelets | Hereditary thrombocytopenia |
Schistocytes | DIC, TTP, HUS |
Blasts | Bone marrow disorder |
Dacrocytes | Myelofibrosis |
Spherocytes RBC clumping |
Evans syndrome |
Nucleated RBCs | Hemolytic anemia, myelofibrosis, infiltration of the bone marrow |
Lymphocytosis Neutrophilia Lymphocytosis Leukopenia Granulations |
Infection |
Macrocytosis Hypersegmented neutrophils |
Megaloblastic anemia e.g. vitamin B12 deficiency, folate deficiency |
Leukemic cells | Hematological malignancies |
Pancytopenia | Aplastic anemia, myelodysplastic syndrome, leukemia |
Microspherocytes | Evans syndrome, thrombotic angiopathies |
Macrocytosis | Vitamin B12 deficiency, folate deficiency |
Parasites | Malaria |
Indications for Platelet Transfusion in Thrombocytopenia
Prophylactic Indications
Therapeutic Indications
WHO Bleeding Grades
Below is a table depicting the WHO bleeding grades for therapeutic platelet transfusion.[6][7]
Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
---|---|---|---|---|
None |
Do's
- Order a peripheral blood smear in all patients with thrombocytopenia and check out the morphology of all blood cells lineages. The peripheral blood smear is one of the most important tests to order in the evaluation of thrombocytopenia.
- Consider the following diagnoses in the following categories of patients:
- Critically ill patients: leukemia, manifested by blasts, and thrombotic microangiopathy, characterized by the presence of schistocytes
- Hospitalized patients: HIT and DIC
- Cardiac surgery patients: mechanical destruction, hemodilution, drug induced thrombocytopenia
- Patients undergoing PCI: Drug induced thrombocytopenia (GpIIb-IIIa inhibitors)
- Pregnant women: Gestational thrombocytopenia, preeclampsia, ITP
- If drug induced thrombocytopenia is suspected, stop the possible offending drug.
- Consider isolated thrombocytopenia in patients with thrombocytopenia in the absence of any systemic symptoms and the absence of any abnormalities in the other blood cells lineages.
- Order a bone marrow aspirate and biopsy in case of severe unexplained thrombocytopenia.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Stasi R (2012). "How to approach thrombocytopenia". Hematology Am Soc Hematol Educ Program. 2012: 191–7. doi:10.1182/asheducation-2012.1.191. PMID 23233580.
- ↑ 2.0 2.1 2.2 2.3 Greenberg EM, Kaled ES (2013). "Thrombocytopenia". Crit Care Nurs Clin North Am. 25 (4): 427–34, v. doi:10.1016/j.ccell.2013.08.003. PMID 24267279.
- ↑ Farid J, Gul N, Qureshi WU, Idris M (2012). "Clinical presentations in immune thrombocytopenic purpura". J Ayub Med Coll Abbottabad. 24 (2): 39–40. PMID 24397048.
- ↑ Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S (2012). "Prevalence and characterization of thrombocytopenia in pregnancy in Indian women". Indian J Hematol Blood Transfus. 28 (2): 77–81. doi:10.1007/s12288-011-0107-x. PMC 3332269. PMID 23730013.
- ↑ Abdel Karim N, Haider S, Siegrist C, Ahmad N, Zarzour A, Ying J; et al. (2013). "Approach to management of thrombotic thrombocytopenic purpura at university of cincinnati". Adv Hematol. 2013: 195746. doi:10.1155/2013/195746. PMC 3876823. PMID 24396345.
- ↑ Slichter SJ (2007). "Evidence-based platelet transfusion guidelines". Hematology Am Soc Hematol Educ Program: 172–8. doi:10.1182/asheducation-2007.1.172. PMID 18024626.
- ↑ Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group (2009). "Recommendations for the transfusion of plasma and platelets". Blood Transfus. 7 (2): 132–50. doi:10.2450/2009.0005-09. PMC 2689068. PMID 19503635.